A new study in the journal Lancet has found that an epidemic of new infections is not only occurring in America, but also in other parts of the world.
New infections, as a percentage of overall cases, have grown in the US from around 1.2% in 2014 to 2.2%.
And while the US still has some of the highest infection rates of any developed country, the study shows that many other developed countries are catching up in recent years.
New infections in other developed nations were on average lower than the US by 0.9% in 2016.
The United States has seen a sudden spike in new infections since 2014.
But in other countries, such as Brazil and the UK, infections have been falling since 2016, according to the report.
It was in 2017 that the US became the only country in the world with a rate of new infection of 2.1%, according to the report.
This trend has continued even after the US economy has recovered from the Great Recession.
Researchers from the University of California-Davis School of Public Health analysed the infection rate for all 50 US states and the District of Columbia from December 2016 to June 2017, using data from the Centers for Disease Control and Prevention (CDC).
They found that the number of new cases has dropped in each state since 2014, but not in the majority of the US.
What’s more, the researchers say that there is evidence that these drops are not driven by a drop in infections, but are rather linked to a rise in the number and spread of other infections, such a drug resistant strain of MRSA.
According to the CDC, MRSA is a resistant bacteria that can be passed from person to person through the bloodstream.
It can cause pneumonia and is increasingly becoming a threat to healthcare workers.
When new infections increase in countries, it can also lead to a higher risk of new cancers.
In a paper published in the American Journal of Public Library Science, researchers at the University at Buffalo looked at the rate of infections in 23 developing countries, including the US, and found that overall infections had declined in the region since 2014 (although it did see a slight rise in infections in 2018).
In contrast, in many of the countries studied, infections are growing and spreading rapidly.
“The data suggests that a dramatic increase in new infection rates in some of these countries, particularly in Latin America and sub-Saharan Africa, could have a major impact on public health,” Dr. Richard Shumaker, a professor of health systems and public health at the university, said in a statement.
In the US the number one factor for new infections, according the study, was the rate at which new infections were spread among people who are in close contact with a patient.
That rate was 2.6% in 2018, compared to 3.5% in the same year in the UK.
While that is not a huge increase, it is still higher than the global average, and is about double the global rate of 0.3%.
The researchers say they expect the number at risk will grow in the coming years, and they say it will be important to be prepared.
“We have seen that new infections and associated morbidity and mortality have increased markedly in the last few years,” Dr Shumakers said.
However, the research has limitations.
For one, the data is based on cases and not people infected.
The researchers also note that their results may be influenced by the different reporting of infections, which can lead to lower estimates of infections overall.
For instance, in the study the researchers found that infections in adults were about three times more likely to be linked to infections in children than in adults, but the researchers did not compare this to cases.
And it is important to remember that some infections are not transmitted through direct contact with the person they are transmitted to, so it is possible that the rates of infections and deaths in people who have not had contact with infected people are lower than in people in close proximity.
But the researchers said that the study did provide valuable information on how the US healthcare system is dealing with infections.
“The US healthcare systems are in a better position to deal with this challenge,” Dr James P. Schafer, an associate professor of epidemiology and public policy at the Johns Hopkins Bloomberg School of Government, told CNN.
However, he said, there is more work to be done before we can say how well the US is tackling this problem.
He said it would be helpful to look at the impact of the epidemic in the states and see how they compare to the US overall.
“In addition, it would also be useful to compare the infections that are being experienced in different states, so that we can determine how they are distributed,” Dr Schafer said.
Dr Shumak said that he was hopeful